Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PINDOLOL | 15MG | TABLET | Resolved | 2023-06-19 | 2023-07-12 | 195533 |
| TEVA-PINDOLOL | 5MG | TABLET | Resolved | 2019-08-22 | 2021-06-03 | 92212 |
| TEVA-PINDOLOL | 5MG | TABLET | Resolved | 2021-07-29 | 2021-09-02 | 143265 |
| TEVA-PINDOLOL | 15MG | TABLET | Resolved | 2023-04-27 | 2023-07-05 | 190737 |
| TEVA-PINDOLOL | 15MG | TABLET | Resolved | 2021-06-10 | 2021-07-09 | 140672 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2021-03-18 | 2021-04-21 | 135971 |
| TEVA-PIROXICAM | 10MG | CAPSULE | Resolved | 2020-10-22 | 2020-11-07 | 126930 |
| TEVA-PIROXICAM | 10MG | CAPSULE | Resolved | 2018-03-13 | 2018-05-11 | 42570 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195903 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2023-10-19 | 2024-02-15 | 207435 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2022-10-17 | 2023-10-19 | 172024 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-05-19 | 2022-12-22 | 161003 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161964 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163927 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2023-10-05 | 2024-01-11 | 206395 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2021-04-21 | 2021-05-13 | 137893 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-05-20 | 2021-08-13 | 139737 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-05-03 | 2024-12-13 | 226936 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-05-09 | 2024-10-17 | 227468 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-06-07 | 2024-11-01 | 229948 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-TECNAL C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Discontinued | 2019-04-11 | 2019-04-11 | 81353 |
| TEVA-TENOFOVIR | 300MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256088 |
| TEVA-TOPISONE | 0.05% | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231589 |
| TEVA-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256104 |
| TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
| TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120024 |
| TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120027 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120030 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |